(Q48379418)

11 February 2018

title

Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease. (English)

1 reference

11 February 2018

0 references

0 references

Hamzaoui K

1

1 reference

11 February 2018

Hamzaoui A

2

1 reference

11 February 2018

Ghorbel I

3

1 reference

11 February 2018

Khanfir M

4

1 reference

11 February 2018

Houman H

5

1 reference

11 February 2018

publication date

1 December 2006

1 reference

11 February 2018

Scandinavian Journal of Immunology

published in

1 reference

11 February 2018

volume

64

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

655-660

1 reference

11 February 2018

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Interleukin 15: biology and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

The Behcet's disease activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Neuro-Behçet syndrome presenting as acute meningeal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Behçet's disease as an autoinflammatory disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

Raised serum interleukin 15 levels in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01844.X

10.1111/J.1365-3083.2006.01844.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

17083622

1 reference

11 February 2018